Harvest Technology p.l.c. – Ordinary Shares Issue

MeDirect Bank (Malta) plc would like to announce that applications for anyone interested in the Proposed Offer for Sale of Ordinary Shares having a nominal value of €0.50 each in Harvest Technology p.l.c. (C 63276) at an Offer Price of €1.50 per share will be accepted as from the 26th November 2019. 

The Board of Directors of 1923 Investments p.l.c. (C 63261) (the “Company”) announced that it has approved the sale of 40% of its shareholding in Harvest Technology p.l.c. (C 63276) (“Harvest Technology”) through an initial public offering. Application has been submitted by Harvest Technology to the Listing Authority, the Malta Financial Services Authority and also to the Malta Stock Exchange for the admission of its entire issued share capital to the official list of the Malta Stock Exchange and for trading to commence thereafter.

Harvest Technology’s principal purpose is that of investing and holding interests in companies and other ventures operating in the technology and e-commerce solutions industries across a spread of geographical regions, primarily in Malta, but also in parts of Europe and Africa. The investment interests of the Company lie principally in the delivery of business solutions and technology (including integrated and automated solutions) and payment solutions and related services through three significant operating subsidiaries, which operate separately and distinctly from each other under their respective brand names and under separate management: PTL Limited, APCO Systems Limited and APCO Limited.

The issued share capital of Harvest Technology is €11,390,318 divided into 22,780,636 ordinary shares of a nominal value of €0.50, fully paid-up. The Company holds 20,502,574 ordinary shares representing 90% of the issued share capital of Harvest Technology. The remaining 2,278,062 ordinary shares, representing 10% of the issued share capital of Harvest Technology are held by Prof. Juanito Camilleri holder of identity card number 476266M (“JC”). Each of the Company and JC, in their capacity as shareholders of Harvest Technology, shall be offering 40% of their respective holdings in Harvest Technology at an offer price of €1.50 per share (the “Share Offer”).

Following the regulatory approval, an aggregate of 9,112,256 ordinary shares of a nominal value of €0.50 in Harvest Technology (the “Shares”) are being offered for sale by JC and the Company, which ordinary shares represent the said 40% of the entire issued share capital of Harvest Technology: 8,201,032 ordinary shares having a nominal value of €0.50 in Harvest Technology, representing 36% of its issued share capital, are being offered for sale by the Company, whereas a further 911,224 ordinary shares having a nominal value of €0.50 in Harvest Technology, representing 4% of its issued share capital are being offered for sale by JC, in each case at the said offer price of €1.50 per share.

A total of 5,166,700 ordinary shares having a nominal value of €0.50 are conditionally allocated to Authorised Financial Intermediaries pursuant to placement agreements. A further 600,000 ordinary shares having a nominal value of €0.50 are conditionally reserved for subscription by Preferred Applicants (as defined in the prospectus, being employees and directors of any company forming part of the Hili Ventures Group as at 15 November 2019). The remaining 3,345,556 Shares are available for subscription by the general public.

MeDirect Bank (Malta) plc will be accepting applications for this equity as from the 26th November 2019.

Before making your investment decision, you are requested to read the Prospectus of the new equity. For further information, please call us on (+356) 2557 4400 or send an email to
wealthsolutions@medirect.com.mt.


The information set forth in this article is only for informative purposes and should not be construed as an offer to sell or solicitation of an offer to subscribe for or purchase
any investment. The information provided is subject to change without notice and does not constitute investment advice or any guarantee of returns. Please consider the terms and
conditions governing the relevant investment prior to making any investment decision. Investors should note that at worst they may lose all of their invested principal in the
event of default, insolvency and/or bankruptcy of the relevant issue. The financial instrument discussed may not be suitable for all investors and investors must make their own
informed decisions and seek their own advice regarding the appropriateness of investing in a financial instrument or implementing strategies discussed herein.

MeDirect Bank (Malta) plc has based this document on information obtained from sources it believes to be reliable but which have not been independently verified. MeDirect Bank
(Malta) plc does not therefore provide any guarantees, representations or warranties. The value of any investment or income may go up as well as down and past performance is no
guarantee of any future performance. When an investment is denominated in a currency other than your local or reporting currency, changes in exchange rates may have an adverse effect
on your investment.

MeDirect Bank (Malta) plc, company registration number C34125, is licensed by the Malta Financial Services Authority under the Banking Act (Cap. 371) and the Investment Services Act
(Cap. 370). This material shall not be reproduced in any way, whether in whole or in part. Any unauthorised
disclosure, use or dissemination, either in whole or in part, of the material contained within is strictly prohibited.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.